Quayle Steven N, Sadar Marianne D
Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada.
Cancer Lett. 2007 Aug 28;254(1):137-45. doi: 10.1016/j.canlet.2007.03.003. Epub 2007 Apr 12.
The androgen receptor (AR) is a ligand-activated transcription factor that regulates numerous target genes, including prostate-specific antigen (PSA). We examined the ability of each member of the 14-3-3 family to modulate transcription of PSA through the AR. Despite significant homology within the 14-3-3 family we observed differences in the ability of each isoform to alter the transcriptional activity of the AR. Significantly, 14-3-3 sigma activated PSA-luciferase reporters not only at castrate levels of androgens, but also in the complete absence of androgens. 14-3-3 sigma also increased expression of the endogenous PSA gene in the absence of androgens. Knockdown of the AR by siRNA oligonucleotides abolished activation of these reporters by 14-3-3 sigma. These findings may have greatest significance in hormone refractory prostate cancer where the AR may be activated in a ligand-independent manner.
雄激素受体(AR)是一种配体激活的转录因子,可调节众多靶基因,包括前列腺特异性抗原(PSA)。我们研究了14-3-3家族各成员通过AR调节PSA转录的能力。尽管14-3-3家族成员间存在显著同源性,但我们观察到各亚型改变AR转录活性的能力存在差异。值得注意的是,14-3-3σ不仅在雄激素去势水平下激活PSA荧光素酶报告基因,而且在完全没有雄激素的情况下也能激活。14-3-3σ在没有雄激素的情况下还能增加内源性PSA基因的表达。用小干扰RNA寡核苷酸敲低AR可消除14-3-3σ对这些报告基因的激活作用。这些发现可能在激素难治性前列腺癌中具有最大意义,因为在这种癌症中AR可能以非配体依赖的方式被激活。